Severe COVID-19 infections are at high risk of causing thromboembolic events (TEEs).
However, the usual exams may be unavailable or unreliable in predicting the risk of TEEs at …

Background: The coronavirus disease 2019 (COVID-19) pandemic is a challenge for
intensive care units (ICU) in part due to the failure to identify risks for patients early and the …

Dear Editors, The association between COVID-19 and an increased risk of venous
thromboembolic (VTE) events, particularly in the critically ill, has been well reported. 1 While …

Venous thromboembolism (VTE) risk is increased in patients infected with severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). A key question was whether increased …

Currently, there is no standardized consensus on anticoagulation (AC) among patients with
coronavirus disease (COVID-19), which has an overwhelming bleeding risk. We aimed to …

There were initially three clear lines of evidence in support of an association between
thrombosis and coronavirus disease 2019 (COVID-19), as caused by SARS-CoV-2 (severe …

The novel coronavirus disease, 2019 (COVID–19) evolved as an unprecedented pandemic.
The severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) infection has been …

Background Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed
to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute …

Hypercoagulability is a recognized feature in SARS-CoV-2 infection. There exists a need for
a dedicated risk assessment model (RAM) that can risk-stratify hospitalized COVID-19 …

Simple Summary The aims of this study are:(1) to analyze the risk of vein thrombosis and
pulmonary embolism in patients affected by pneumonia due to Covid-19;(2) to evaluate …